Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008431 |
ID: | TCMBANKHE008431 |
药用植物名: | 牡荆子 |
药用部位: | fruit |
治疗类型: | 止咳平喘药 |
TCM_ID_id: | 1898 |
SymMap_id: | 286 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN001734 | 14-methylhexadecanoicacid | 14-methyl hexadecanoic acid | C17H34O2 | 270.5 g/mol | CCC(C)CCCCCCCCCCCCC(=O)O |
| TCMBANKIN001911 | Encecalin | CHEMBL451983; CHEBI:4789; NSC603929; C09005; 1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone; Ketone, 7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl methyl; 20628-09-5; encecalin; 4CN-1599; SCHEMBL4310132; WXVLCNREBFDEKS-UHFFFAOYSA-N; AKOS032948499; NSC-603929; 1-(7-methoxy-2,2-dimethyl-2h-chromen-6-yl)ethanone; ZINC897924; Isolated from Asteraceae plants; Encecaline; NSC 603929; 1-(7-methoxy-2,2-dimethyl-chromen-6-yl)ethanone; ACon1_002222; 1-(7-methoxy-2,2-dimethylchromen-6-yl)ethanone; Encecalin (methyleupatoriochromene); Ethanone,1-(7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-; W1949; AC1Q5GA2; 6-acetyl-7-methoxy-2,2-dimethylchromene; 1-(7-methoxy-2,2-dimethyl-6-chromenyl)ethanone; MolPort-001-742-371; AC1L3FTK; CTK8D7503; MEGxp0_001567; NP-009521; MCULE-1012949526 | C14H16O3 | 232.27 | CC(=O)C1=C(C=C2C(=C1)C=CC(O2)(C)C)OC |
| TCMBANKIN002350 | 20(s)-ginsenosiderh2 | 20(s)-ginsenoside-rh2 | C36H62O8 | 622.9 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C |
| TCMBANKIN002812 | notoginsenosider2 | notoginsenoside R2; notoginsenoside r2 | C41H70O13 | 771 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(CO6)O)O)O)C)O)C)O)C |
| TCMBANKIN002965 | Ethyl-p-digallate | ethyl-p-digallate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxyphenyl)carbonyloxy-benzoate; AC1NSVBL; 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxy-benzoic acid ethyl ester; (4-ethoxycarbonyl-2,6-dihydroxyphenyl) 3,4,5-trihydroxybenzoate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxybenzoate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxy-benzoate; 3,5-dihydroxy-4-[oxo-(3,4,5-trihydroxyphenyl)methoxy]benzoic acid ethyl ester | 350.3 | CCOC(=O)C1=CC(=C(C(=C1)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O | |
| TCMBANKIN004861 | cyclododecanone | I14-19848; F0001-2129; LS-191395; Z1258578308; MCULE-8431279332; InChI=1/C12H22O/c13-12-10-8-6-4-2-1-3-5-7-9-11-12/h1-11H; MolPort-000-727-778; Cyclododecanone, >=99%; NSC 77116; CTK3E8944; AK609278; NSC77116; AS-10382; KS-00000WK2; CJ-10851; NCGC00163980-02; AKOS000118913; Tox21_201557; BB_NC-0279; DB-056676; DSSTox_GSID_27322; NCGC00163980-01; EC 212-595-6; UNII-WL053118A9; SXVPOSFURRDKBO-UHFFFAOYSA-N; DSSTox_CID_7322; WL053118A9; ANW-37643; TR-037928; NCGC00259106-01; ZINC3860296; RTR-037928; ACMC-209pr1; BBL019121; NCGC00256984-01; STK301634; T8208; ST45061384; CDON; cyclododecan-1-one; W-109097; SCHEMBL190509; CAS-830-13-7; CYCLODODECANONE; HSDB 5762; 830-13-7; NSC-77116; DTXSID3027322; FT-0624164; DSSTox_RID_78407; AC1L21CI; MFCD00003722; cyclododecanon; EINECS 212-595-6; KSC448S4J; Tox21_303048; CHEMBL1883853; SBB060076; TRA0043398; 6022AF | C12H22O | 182.3 g/mol | C1CCCCCC(=O)CCCCC1 |
| TCMBANKIN004971 | dicapryl phthalate | SCHEMBL167309; Jsp001875 | C24H42O4 | 394.6 g/mol | CCCCCCCC.CCCCCCCC.C1=CC=C(C(=C1)C(=O)O)C(=O)O |
| TCMBANKIN006089 | lycopodine | C16H25NO | 247.38 g/mol | CC1CC2CC(=O)C3CCCN4C3(C1)C2CCC4 | |
| TCMBANKIN007637 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN010290 | coprine | 2-amino-5-[(1-hydroxycyclopropyl)amino]-5-oxopentanoic acid; AC1NAMAQ; 2-amino-4-[(1-hydroxycyclopropyl)carbamoyl]butanoic acid; L-coprine | C8H14N2O4 | 202.21 g/mol | C1CC1(NC(=O)CCC(C(=O)O)N)O |
| TCMBANKIN012769 | 3-o-[β-d-glucopyranosyl(1→6)-β-d-glucopy-ranosyl]-20-o-β-d-glucopyranosyl-3β,12β,20(s)-trihydroxydammar-24-ene | C48H82O18 | |||
| TCMBANKIN015100 | flavonoid glycoside | ||||
| TCMBANKIN015475 | clavatol | Lyclavatol; Clavatol; 33044-79-0 | C10H12O3 | 180.2 g/mol | CC1=CC(=C(C(=C1O)C)O)C(=O)C |
| TCMBANKIN018519 | 2,8-dimethyl-undecanoic | ||||
| TCMBANKIN018728 | alpha-onocerin | (2S,4aR,5S,8aR)-5-{2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl]ethyl}-1,1,4a-trimethyl-6-methylenedecahydronaphthalen-2-ol; MolPort-006-111-540; GESZMTVZGWZBPW-IHIDZKKCSA-; 2-Naphthalenol,5,5'-(1,2-ethanediyl)bis[decahydro-1,1,4a-trimethyl-6-methylene-,(2S,2'S,4aR,4'aR,5S,5'S,8aR,8'aR)-; 8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol; (3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol; ZINC38605938; alpha-Onocerol; α-onocerin; C21734; Alpha-onocerin, primary pharmaceutical reference standard; CHEBI:138303; (2S,4AR,5S,8AR)-5-{2-[(1S,4AR,6S,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]ETHYL}-1,1,4A-TRIMETHYL-6-METHYLIDENE-HEXAHYDRO-2H-NAPHTHALEN-2-OL; MCULE-4277793393; EINECS 208-118-6; W2391; 511-01-3; InChI=1/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1; alpha-Onocerin; SC-97924; (+)-alpha-onocerin | C30H50O2 | 442.7 g/mol | CC1(C2CCC(=C)C(C2(CCC1O)C)CCC3C(=C)CCC4C3(CCC(C4(C)C)O)C)C |
| TCMBANKIN019381 | Pancratistatin | C08535; 96203-70-2; NCI60_003105; pancratistatin; SMP1_000217; NSC349156; NCIMech_000573; AC1O8OET; (1R,2S,3R,4R,4aS,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one | C14H15NO8 | 325.27 | C1OC2=C(O1)C(=C3C(=C2)C4C(C(C(C(C4O)O)O)O)NC3=O)O |
| TCMBANKIN020399 | clavolonine | Clavolonine | C16H25NO2 | 263.37 g/mol | CC1CC23C4CCCN2CCCC3C(=O)CC4C1O |
| TCMBANKIN020564 | 2,6-di-tert-butyl-4-methy-phenol | ||||
| TCMBANKIN020792 | lycoclavanin | C30H48O5 | 488.7 g/mol | CC1(C(C(CC2(C1C(=O)CC3=CC4(CCC5C(C4CCC32)(CCC(C5(C)CO)O)C)C)C)O)O)C | |
| TCMBANKIN023506 | 3,4-DIMETHYLBIPHENYL | 4433-11-8; 1,2-dimethyl-4-phenyl-benzene; 1,1'-Biphenyl, 3,4-dimethyl-; 1,2-dimethyl-4-phenylbenzene | C14H14 | 182.26 g/mol | CC1=C(C=C(C=C1)C2=CC=CC=C2)C |
| TCMBANKIN024355 | dithiocyclopentene | 288-74-4; 1,3-dithiol; 1,3-dithiole; SCHEMBL22569; CTK0J1746; AC1NSUXX; DTXSID40415715 | C5H8S2 | 132.3 g/mol | C1CC(=C(C1)S)S |
| TCMBANKIN024507 | 1,1,5,5-tetramethyl-4-methano-2,3,4,6,7,10-hexahydronaphthalene | 1,1,5,5-tetramethyl-4-methylidene-3,4a,6,7-tetrahydro-2H-naphthalene; AC1NT0Y7 | CC1(CCC=C2C1C(=C)CCC2(C)C)C | ||
| TCMBANKIN024983 | notoginsenosider4 | notoginsenoside r4; Notoginsenoside R4; AC1NSZ7O | C59H100O27 | 1241.59 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O)O)C |
| TCMBANKIN025182 | 3(-E)-p- coumaroyl betulin | ||||
| TCMBANKIN025846 | Mycosinol | AC1NQY4E; (3E)-3-hexa-2,4-diynylidene-4,9-dioxaspiro[4.4]nona-1,7-dien-6-ol; (2E)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-ol; (2E)-2-Hexa-2,4-diynylidene-1,6-dioxaspiro(4.4)nona-3,7-dien-9-ol; NSC-653382; mycosinol; 111768-19-5; CHEBI:7038; C08455; NSC653382; CHEMBL1968944 | C13H10O3 | 214.22 | CC#CC#CC=C1C=CC2(O1)C(C=CO2)O |
| TCMBANKIN027128 | aucubigenin | 64274-28-8; (1R,4aR,5S,7aS)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1,5-diol; Cyclopenta(c)pyran-1,5-diol, 1,4a,5,7a-tetrahydro-7-(hydroxymethyl)-, (1R-(1alpha,4aalpha,5alpha,7aalpha))-; (1R,4aR,5S,7aS)-7-methylol-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1,5-diol | C9H12O4 | 184.19 | C1=COC(C2C1C(C=C2CO)O)O |
| TCMBANKIN027416 | deta-elemene | C15H24 | 204.35 | ||
| TCMBANKIN028494 | lucidoline | ||||
| TCMBANKIN030268 | obscurine | C24H31NO3 | 381.5 g/mol | CC(C)CNC(=O)C=CC1C2CCCCC2C=CC1C3=CC4=C(C=C3)OCO4 | |
| TCMBANKIN031251 | phlegmariurine | C16H23NO2 | 261.36 g/mol | CC1CC2CC(=O)C3=C2CCCN(CCC3)C(=O)C1 | |
| TCMBANKIN031979 | clavatine | C16H25NO2 | CC1CC2CC(=O)C3(CCCN4C3(C1)C2CCC4)O | ||
| TCMBANKIN032647 | Isoaloesin | 7-hydroxy-5-methyl-2-(2-oxopropyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 7-hydroxy-5-methyl-2-(2-oxopropyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 2-acetonyl-7-hydroxy-5-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; isoaloesin; 2-acetonyl-7-hydroxy-5-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 2-acetonyl-7-hydroxy-5-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone | 410.41 | CC1=C2C(=CC(=C1OC3C(C(C(C(O3)CO)O)O)O)O)OC(=CC2=O)CC(=O)C | |
| TCMBANKIN032998 | 3β-o-β-d-glucopyranosyl-20-o-[α-l-arabino-pyranosyl(1→2)-β-d-glucopyranosyl]3β,12β,20(s)-trihydroxydammar-24-ene | C47H80O17 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C | ||
| TCMBANKIN033879 | panaxatriol | (3beta,6alpha,12beta,20R)-20,25-Epoxydammarane-3,6,12-triol; Panaxatriol; UPCMLD-DP046:002; SR-05000002178-2; 32791-84-7; (20S)-Panaxatriol; NSC 308880; SR-05000002178; NCGC00161615-01; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyltetrahydropyran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; AIDS031251; MolPort-039-338-080; Dammarane-3,6,12-triol, 20,25-epoxy-, (3.beta.,6.beta.,12.beta.,20R)-; CCG-208596; AIDS-031251; UPCMLD-DP046:001; Ambotz32791-84-7; ZINC17654227; UPCMLD-DP046; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyl-2-tetrahydropyranyl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; CHEMBL1357750 | C30H52O4 | 476.73 | CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)O)C)C |
| TCMBANKIN035035 | epsilon-Cadinene | AC1NST8E; (4aR)-4,7-dimethylidene-1-propan-2-yl-1,2,3,4a,5,6,8,8a-octahydronaphthalene; epsilon-cadinene | C15H24 | 204.35 g/mol | CC(C)C1CCC(=C)C2C1CC(=C)CC2 |
| TCMBANKIN035097 | 1-Methyl-4-isoallyl-cyclohexane | 1-methyl-4-[(E)-prop-1-enyl]cyclohexane; 1-methyl-4-isoallyl-cyclohexane; AC1NSYG7 | C10H18 | 138.28 | CC=CC1CCC(CC1)C |
| TCMBANKIN035440 | dauricine | AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4 | C38H44N2O6 | 624.77 | CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
| TCMBANKIN036312 | 20-Hexadecanoylingenol | 20-hexadecanoylingenol | C36H58O6 | 586.94 | CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
| TCMBANKIN036873 | Ginsenoside Rd | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6 | 947 | ||
| TCMBANKIN036909 | Notoginsenoside R1 | A839906; notoginsenosider1; notoginsenoside r1 ; 2-(hydroxymethyl)-6-[2-[6-[6-(hydroxymethyl)-3-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-en-2-yl]oxy-oxane-3,4,5-triol; oxa; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahyd; 80418-24-2; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahy; C08961; 2-[2-[6-[[4,5-dihydroxy-6-(hydroxymethyl)-3-methyl-2-oxanyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; oxane-2,3,4; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,1; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,1; Notoginsenoside R1 | C47H80O18 | 933 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]5([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H] )[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[C@@]7([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] |
| TCMBANKIN037001 | alpha-Guaiene | (1S,4S,7R)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene; alpha-guaiene; α-guaiene; (1S,4S,7R)-7-isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene | C15H24 | 204.35 g/mol | CC1CCC(CC2=C1CCC2C)C(=C)C |
| TCMBANKIN037051 | notoginsenoside D | C64H108O31 | 1374 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[C@@]3([H])O[C@]([H])(C([H])([H])O[C@@]4([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]2([H])O[H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]8([H])O[C@]([H])(C([H])([H])O[ H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[C@@]9([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[C@@]%10([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]%10([H])O[H] | |
| TCMBANKIN037219 | quinquenoside IV | C54H90O24 | 1123 | C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])[C@]([H])(O[H])[C@]3(C([H])([H])[H])[C@]2([H])C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C (/C([H])([H])[H])\C([H])([H])[H])O[C@@]4([H])O[C@@]([H])(C([H])([H])O[C@@]5([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]5([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]4([H])O[H]) C([H])([H])C6([H])[H])[C@]36C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[C@@]8([H])O[C@@]([H])(C([H])([ H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]8([H])O[H] | |
| TCMBANKIN037364 | Cyclo-(Leu-Tyr) | 276.33 g/mol | |||
| TCMBANKIN037406 | notoginsenoside H | C47H80O19 | 949 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](OC#CC#CC#C[H])(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([ H])O[H])C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]5([H])O[C@]6([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[C@]7([H ])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H].[H][H].[H][H].[H][H].[H][H].[H][H] | |
| TCMBANKIN037434 | quinquenoside II | C63H106O24 | 1247 | [C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])OC(=O)\C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O [H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(OC([H])([H])[C@]([H])(O[C@ ]4([H])C([H])([H])O[C@]([H])(O[C@]5([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]5([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]4([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([ H])([H])[H])C([H])([H])C6([H])[H])[C@@]67C([H])([H])[H])[C@@]7(C([H])([H])[H])C([H])([H])C8([H])[H])[C@@]8([H])C1(C([H])([H])[H])C([H])([H])[H] | |
| TCMBANKIN037943 | cyclo-(ile-ala) | C9H16N2O2 | 184.24 g/mol | CCC(C)C1C(=O)NC(C(=O)N1)C | |
| TCMBANKIN038189 | gypenoside XVII | Gypenoside XVII; gypenosidexvii; gypenosideXVII | C48H82O18 | 947 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@]([H])(O[C@]([H])(C([H])([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]2([H])O[H])[C@]( [H])(O[H])[C@@]2([H])O[H])[C@@]3([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@ @]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]7([H])O[H] |
| TCMBANKIN038204 | ferulic acid | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid | C10H10O4 | 194.18 | COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
| TCMBANKIN038296 | quinquenoside V | C60H102O28 | 1271 | [C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H])C([H])([H])[C@ ](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]4([H])O[C@]([H])(C([H])([H])O[C@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[C@@]6([H])O[C@]([ H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@]([H])(O[H])[C@@]5([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H]) ([H])[H])C([H])([H])C7([H])[H])[C@@]78C([H])([H])[H])[C@@]8(C([H])([H])[H])C([H])([H])C9([H])[H])[C@@]9([H])C1(C([H])([H])[H])C([H])([H])[H] | |
| TCMBANKIN038532 | δ-Cadinene | δ- cadinene | 204.39 | ||
| TCMBANKIN038539 | δ-Guaiene | δ- guaiene | |||
| TCMBANKIN039287 | Panaxydol | 72800-72-7; (3R)-8-[(2R,3S)-3-heptyloxiran-2-yl]oct-1-en-4,6-diyn-3-ol; panaxydol ; (3R)-8-[(2R,3S)-3-heptyl-2-oxiranyl]oct-1-en-4,6-diyn-3-ol; 1-Octene-4,6-diyn-3-ol, 8-(3-heptyloxiranyl)-; 2alpha-Heptyl-3beta-(6-hydroxy-7-octene-2,4-diynyl)oxirane | 260.371 | ||
| TCMBANKIN039620 | Cyclo-(Ala-Pro) | 168.19 g/mol | |||
| TCMBANKIN040012 | cyclo-(phe-ala) | C12H14N2O2 | CC1C(=O)NC(C(=O)N1)CC2=CC=CC=C2 | ||
| TCMBANKIN040211 | Ginsenoside Rg1 | ginsenosiderg1; ginsenoside r g1; sanchinoside C1; (20S)-3beta,12beta-Dihydroxy-4,4,8beta,14alpha-tetramethyl-6alpha,20-bis(beta-D-glucopyranosyloxy)-18-norcholestane-24-ene | 801.01 | ||
| TCMBANKIN040212 | Cyclo-(Leu-Ala) | 184.24 g/mol | |||
| TCMBANKIN040419 | panaxytriol | (3R,9S,10S)-Panaxytriol; SCHEMBL87655; heptadeca-1-ene-4,6-diyne-3,9,10-triol; Panaxytriol | C17H26O3 | 278.39 | CCCCCCCC(C(CC#CC#CC(C=C)O)O)O |
| TCMBANKIN040444 | ginsenoside rc | 2-[[2-[[17-[2-[[6-[[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]oxymethyl]-3,4,5-trihydroxy-2-oxanyl]oxy]-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydr; ginsenosiderc; I06-0733; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-[[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,10,14-tetramethyl-12-oxidanyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocy; A802167 | C53H90O22 | 1079.27 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C |
| TCMBANKIN040797 | azelaic acid | 8-carboxylatooctanoate; CJ-24076; 9-oxido-9-oxononanoate; AC1MWLWR; azelaate(2-); azelaicacid; 8-Carboxyoctanoate; CHEBI:78208; nonanedioate(2-); azelate; nonanedioate; azelaate; A805183 | C9H16O4 | 188.221 | C([H])([H])(C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O |
| TCMBANKIN041265 | β,β-Dimethylacrylalkannin | beta,beta-dimethylacrylalkannin | 370.4 g/mol | ||
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN041320 | cyperene | Cyperene; 2387-78-2; (-)-cyperene; LMPR0103450002; α-cyperene; 3H-3a,7-Methanoazulene, 2,4,5,6,7,8-hexahydro-1,4,9,9-tetramethyl-, (3aR-(3aalpha,4beta,7alpha))- | C15H24 | 204.351 | C1([H])([H])C([H])([H])C(C([H])([H])[H])=C2[C@@]13C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(C2([H])[H])C([H])([H])C([H])([H])[C@@]3([H])C([H])([H])[H] |
| TCMBANKIN041461 | Cyclo-(Leu-Ile) | 226.32 g/mol | |||
| TCMBANKIN041496 | cyclo-(leu-thr) | C10H18N2O3 | CC(C)CC1C(=O)NC(C(=O)N1)C(C)O | ||
| TCMBANKIN042311 | (S)-Dencichine | ||||
| TCMBANKIN042337 | Ditertbutyl phthalate | Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6 | C16H22O4 | 278.34 | CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C |
| TCMBANKIN042413 | Notoginsenoside B | 1123.3 g/mol | |||
| TCMBANKIN042614 | quinquenoside III | C50H84O19 | 989 | [C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])OC(C([H])([H])[H])=O)[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H ])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H]) C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C1(C([H])([H])[H])C([H])([H])[H] | |
| TCMBANKIN042955 | Notoginsenoside M | 963.2 g/mol | |||
| TCMBANKIN043074 | notoginsenoside N | C48H82O19 | 963 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])(C([H] )([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@]5([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H]) [C@@]([H])(O[C@@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN043169 | Cyclo-(Ala-Val) | ||||
| TCMBANKIN043264 | notoginsenoside K | C48H82O18 | 947 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2 ([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H ])[H])[C@@]1([H])O[C@]6([H])O[C@]([H])(C([H])([H])O[C@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H] | |
| TCMBANKIN043280 | notoginsenoside J | C42H74O16 | 835 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])(C([H] )([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@]5([H])O[C@@]6([H])O[C@]([H])(C([H] )([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN043469 | γ-Elemene | O-Menth-8-ene, 4-isopropylidene-1-vinyl-; 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-cyclohexane; γ- elemene; γ--elemene; γ-Elernene | 204.35 | ||
| TCMBANKIN043534 | Notoginsenoside Fe | notoginsenoside fe | C47H80O17 | 917.13 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(O7)CO)O)O)O)O)O)C |
| TCMBANKIN043634 | notoginsenoside g | C48H80O19 | 961.1 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(C(C=C4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C | |
| TCMBANKIN043775 | cycloeucalenol | 4alpha,14-dimethyl-9beta,19-cyclo-5alpha-ergost-24(28)-en-3beta-ol; 9,19-Cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-; 469-39-6; C02141; AKOS032948711; cycloleucalenol; CHEBI:16653; cycloeucalenol; 3beta,4alpha,5alpha-4,14-dimethyl-9,19-cycloergost-24(28)-en-3-ol | C30H50O | 427 | [C@]1([H])(O[H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])[C@@]3([C@@]4(C3([H])[H])[C@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@]5([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=C([H])[H])C( [H])(C([H])([H])[H])C([H])([H])[H])[H])[C@]5(C([H])([H])[H])C([H])([H])C4([H])[H])C([H])([H])C2([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN044254 | Notoginsenoside A | AC1O52SM; .beta.-D-Glucopyranoside, (3.beta.,12.beta.)-20-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-12,25-dihydroxydammar-23-en-3-yl 2-O-.beta.-D-glucopyranosyl-; Notoginsenoside A; 193895-21-5; beta-D-Glucopyranoside, (3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12,25-dihydroxydammar-23-en-3-yl 2-O-beta-D-glucopyranosyl- | 1125.3 g/mol | ||
| TCMBANKIN044577 | notopterol | AX8245234; 4-[(2E)-5-hydroxy-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one; CHEMBL258939; MFCD23701669; Notopterol; ST24035054; 4CH-024741; AK119818; CHEBI:81136; C17499; MolPort-027-836-284; (E)-4-((5-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((5-hydroxy-3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-; AC1NSZ7R; BG01067911; BDBM50375219; 88206-46-6; 4-{[(2E)-5-HYDROXY-3,7-DIMETHYLOCTA-2,6-DIEN-1-YL]OXY}FURO[3,2-G]CHROMEN-7-ONE; KB-209244; AKOS016010745; 5[(2E)-5-hydroxy-3,7-dimethyl-2,6-octadienyloxy]psoralen | C22H24O4 | 352.424 | c12c(oc([H])c1[H])c([H])c3c(C([H])=C([H])C(=O)O3)c2OC([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[C@]([H])(C([H])([H])[H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H] |
| TCMBANKIN044580 | Fawcettiine | C18H29NO3 | C1([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@@]([H])(O[H])[C@@]([H])(C([H])([H])[H])C2([H])[H])C([H])([H])[C@@]3([H])OC(C([H])([H])[H])=O)[C@]2([C@]3([H])C([H])([H])C([H])([H])C4([H])[H])N4C1([H])[H ] | ||
| TCMBANKIN044583 | cyclo-(phe-val) | C14H18N2O2 | 246.3 g/mol | CC(C)C1C(=O)NC(C(=O)N1)CC2=CC=CC=C2 | |
| TCMBANKIN044942 | Quercetin-3-L-arabinon-7-D-glucoside | Quercetin-3-L-arabinon-7-D-glucoside; Quercetin-3-O-malonyl-beta-D-glucoside; quercetin-3-l-arabinon-7-d-glucoside | C26H28O17 | 464.38 | c1([H])c(O[H])c(C(=O)C(O[C@]2([H])O[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]2([H])O[H])=C(c3c([H])c(O[H])c(O[H])c([H])c3[H])O4)c4c([H])c1O[C@]5([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])( O[H])[C@@]([H])(C([H])([H])O[H])O5 |
| TCMBANKIN046177 | cyclo-(leu-val) | C11H20N2O2 | 212.29 g/mol | CC(C)CC1C(=O)NC(C(=O)N1)C(C)C | |
| TCMBANKIN046580 | methyl pyroglutamate | C6H9NO3 | 143.141 | C1([H])([H])C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)N([H])C1=O | |
| TCMBANKIN046802 | notoginsenoside C | C55H94O25 | 1155 | C([H])([H])(O[H])[C@@]1([H])O[C@](O[C@@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@@]([C@]([C@@](C([H])([H])[H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[ H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])O3)C([H])([H])C([H])([H])[C@]([H])(OO[H])C(C([H])([H])[H])=C([H])[H])([H]) C([H])([H])C5([H])[H])([H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@]7([H])C2(C([H])([H])[H])C([H])([H])[H])([H])[C@]([H])(O[C@@](C([H])([H])[H])([C@]([H])(O[H])[C@@]8([H]) O[H])O[C@]([H])(C([H])([H])O[H])[C@@]8([H])O[H])[C@@]([H])(O[H])[C@]1([H])O[H] | |
| TCMBANKIN047056 | Cyclo-(Pro-Val) | 196.25 g/mol | |||
| TCMBANKIN047183 | Cyclo-(Leu-Ser) | ||||
| TCMBANKIN047281 | Notoginsenoside L | 1079.3 g/mol | |||
| TCMBANKIN048156 | cyperol | CHEMBL2268862; APWLDLGOYJHNIK-YUELXQCFSA-N; C16945; 20084-99-5; DTXSID70555532; (2R,4aS,7R)-1,4a-Dimethyl-7-(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-ol; 3ALPHA-HYDROXY-CYPERONE; Cyperol; CHEBI:80813 | C15H24O | 220.35 | CC1=C2CC(CCC2(CCC1O)C)C(=C)C |
| TCMBANKIN048280 | Notoginsenoside I | 1093.3 g/mol | |||
| TCMBANKIN048530 | quinquenoside i | C52H86O19 | 1015.2 g/mol | CC=CC(=O)OCC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)C)CO)O)O)O)O)O | |
| TCMBANKIN048691 | alpha-Guttiferin | alpha-guttiferin | C27H32O6 | 452.59 | C1(C([H])([H])[H])=C(C([H])([H])[H])c2c(c(C(=O)C(\C(=C(/C([H])([H])C([H])([H])[H])\O[H])\[C@@]([H])(C([H])([H])[H])C([H])([H])C3([H])[H])=C3[H])c(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H ])[H])c2O[H])OC1=O |
| TCMBANKIN049364 | 6-o-β-d-glucopyranosyl-5-hydroxyangelicin | C17H16O10 | C1=CC(=O)OC2=C1C(=C(C3=C2C=CO3)OC4C(C(C(C(O4)CO)O)O)O)O | ||
| TCMBANKIN049472 | sanchinoside b1 | C36H62O9 | 638.9 g/mol | CC(=CCCC(C)(C)O)C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C | |
| TCMBANKIN049515 | cyclo-(phe-tyr) | C18H18N2O3 | 310.3 g/mol | C1=CC=C(C=C1)CC2C(=O)NC(C(=O)N2)CC3=CC=C(C=C3)O | |
| TCMBANKIN050143 | 4,4'-Diketo-3-hydroxy-beta-carotene | beta,beta-Carotene-4,4/'-dione, 3-hydroxy-; 3-Hydroxycanthaxanthin; beta-Carotene-4,4'-dione, 3-hydroxy-, all-trans-; Phenicoxanthin; 3-Hydroxy-beta,beta-carotene-4,4'-dione; SCHEMBL149807; 4418-72-8; beta,beta-Carotene-4,4'-dione, 3-hydroxy-; 4,4'-diketo-3-hydroxy-β-carotene; 3-Hydroxy-4,4'-diketo-beta-carotene; All-trans-adonirubin; 4,4'-Diketo-3-hydroxy-beta-carotene | C40H52O3 | 580.8 g/mol | [C@]1([H])(O[H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C(\C([H])=C([H])\C(\C([H])([H])[H])=C([H])/C([H])=C([H])\C(\C([H])([H])[H])=C([H])\C([H])=C([H])\C([H])=C(/C([H])([H])[H])\C([H])=C([H])\C([ H])=C(/C([H])([H])[H])\C([H])=C([H])\C2=C(C([H])([H])[H])C(=O)C([H])([H])C([H])([H])C2(C([H])([H])[H])C([H])([H])[H])=C(C([H])([H])[H])C1=O |
| TCMBANKIN050180 | Isobutyl pyroglutamate | ||||
| TCMBANKIN057925 | l-α-amino-β-oxalylaminopropionicacid | N(3)-(carboxylatoformyl)-L-2,3-diaminopropionate(1-); N3-oxalyl-L-2,3-diaminopropionic acid; (2S)-2-ammonio-3-[(carboxylatocarbonyl)amino]propanoate; beta-N-Oxalyl-L-alpha,beta-diaminopropionate; N-3-oxalyl-L-2,3-diaminopropanoate; (2S)-2-azaniumyl-3-(carboxylatoformamido)propanoate; CHEBI:57758; l-alpha-amino-beta-oxalylaminopropionic acid; N3-Oxalyl-L-2,3-diaminopropanoate; (2S)-2-azaniumyl-3-[(carboxylatocarbonyl)amino]propanoate; L-alpha-Amino-beta-oxalylaminopropionic acid; N(3)-oxalyl-L-2,3-diaminopropanoate | C5H7N2O5- | 175.12 g/mol | C(C(C(=O)[O-])[NH3+])NC(=O)C(=O)[O-] |
| TCMBANKIN057973 | NSC405997 | 22513-81-1; 1,22-Docosanediol; AIDS-471012; AIDS471012; docosane-1,22-diol;DTXSID00324197; CTK1A7857; AKOS028111015; 1,22-Docosanediol; MCULE-8562052651; AC1L873A; SCHEMBL472790; CHEMBL470773; NSC-405997; HIBKFQRBONXURO-UHFFFAOYSA-N; NSC405997; 1,22-hexadecanediol; docosane-1,22-diol;1,22-docosanediol | C22H46O2 | 342.6 g/mol | C(CCCCCCCCCCCO)CCCCCCCCCCO |
| TCMBANKIN058661 | C08464 | 2060-59-5; Tridec-1-ene-3,5,7,9,11-pentayne; 1-Tridecene-3,5,7,9,11-pentyne; 1-Tridecen-3,5,7,9,11-pentayne; tridec-1-en-3,5,7,9,11-pentayne; 1-Tridecene-3,5,7,9,11-pentayne;1-tridecene-3,5,7,9,11-pentyne | C13H6 | 162.19 g/mol | CC#CC#CC#CC#CC#CC=C |
| TCMBANKIN058859 | Notoginsenoside R6 | notoginsenoside r6 | C48H82O19 | 963.2 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)C |
| TCMBANKIN058861 | ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf | C48H82O18 | 947.15 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
| TCMBANKIN058863 | 20-o-β-d-xylopyranosyl(1→6)-β-d-gluco-pyranosyl-20(s)-protopanaxadiol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C | |||
| TCMBANKIN058867 | ginsenoside rb1 | Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII | C54H92O23 | 1109.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C |
| TCMBANKIN058880 | dammarenediol II | dammar-24-ene-3β,20-diol i;dammarane type;ginsenoside;74749-74-9; UNII-3K198YD54P; LS-71251; (3S,5R,8R,9R,10R,14R,17S)-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 3K198YD54P; Ginsenosides; AC1MJ5EP | C30H52O2 | 444.73 | CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O)C |
| TCMBANKIN058936 | Hypnon | 1-Phenylethanone; InChI=1/C8H8O/c1-7(9)8-5-3-2-4-6-8/h2-6H,1H; C07113; Acetylbenzene; ZINC00896628; Ethanone, 1-phenyl-; Acetophenon; 00790_FLUKA; Ketone, methyl phenyl; WLN: 1VR; 442438_SUPELCO; Methyl phenyl ketone; Usaf ek-496; 42163_FLUKA; Ketone, methyl phenyl-; Benzoyl methide; AI3-00575; AIDS-017929; W200905_ALDRICH; FEMA Number 2009; RCRA waste number U004; FEMA No. 2009; Phenyl methyl ketone; NSC 7635; RCRA waste no. U004; NSC7635; A10701_ALDRICH; 98-86-2; CCRIS 1341; AC0; Acetophenone; ST5213401; EINECS 202-708-7; CHEBI:27632; Hypnone; 1-phenylethan-1-one; HSDB 969; Benzoylmethide; 1-Phenyl-1-ethanone; Benzene, acetyl-; c0117; AIDS017929; Acetofenon [Czech]; Acetylbenzol;1-(Phenyl-D5)-Ethanon; NSC 98542-d5; 1-[(2,3,4,5,6-(2)H?)PHENYL]ETHANONE; Acetophenone-(phenyl-d5), 99 atom % D; ACM28077647; DTXSID70466417; Acetophenone-2',3',4',5',6'-d5; Acetophenon-d5; pentadeuterophenyl methyl ketone; FT-0661057; Acetylbenzene-d5; Hypnone-d5; MFCD00064446; 1-(Phenyl-d5)ethanone; 1-(2,3,4,5,6-pentadeuteriophenyl)ethanone; Acetophenone-2/',3/',4/',5/',6/'-d5; SCHEMBL1332185; Methyl (Phenyl-d5) Ketone; DE155; J-016964; 28077-64-7; 1-(Phenyl-d5)-1-ethanone; MolPort-003-929-975; NSC 7635-d5; (Phenyl-d5) Methyl Ketone; Acetophenone-(phenyl-d5); Acetophenone-d5; Acetophenone-2 inverted exclamation marka,3 inverted exclamation marka,4 inverted exclamation marka,5 inverted exclamation marka,6 inverted exclamation marka-d5; Hypnon-d5; 1-Feniletanone-d5; Acetophenone-(phenyl-d5) 99 atom % D; 1-Phenylethanone-d5; Acetophenone-2'3'4'5'6-d5;phenyl-ethanone;acetophenone;phenylethanone;1-phenylethanone | C8H8O | 120.15 g/mol | CC(=O)C1=CC=CC=C1 |
| TCMBANKIN059091 | ditertbutyl phthalate | Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6 | C16H22O4 | 278.34 | CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C |
| TCMBANKIN059097 | 1-Hydroxycumene | alpha,alpha-Dimethylbenzyl alcohol; 2-Phenyl-2-propanol; P30802_ALDRICH; alpha,alpha-Dimethylbenzenemethanol; 617-94-7; .alpha.-Cumyl alcohol; EINECS 210-539-5; alpha,alpha-Dimethylbenzene methanol; 2-Propanol, 2-phenyl-; Phenyldimethylcarbinol; NSC1261; Dimethyl phenyl carbinol; 2-PHENYLISOPROPANOL; Benzyl alcohol, .alpha.,.alpha.-dimethyl-; Dimethylphenylmethanol; BRN 1905012; NSC 1261; NSC212537; Benzenemethanol, .alpha.,.alpha.-dimethyl-; NSC 212537; 4-06-00-03219 (Beilstein Handbook Reference); 2-Phenylpropan-2-ol; HSDB 5718; InChI=1/C9H12O/c1-9(2,10)8-6-4-3-5-7-8/h3-7,10H,1-2H; .alpha.,.alpha.-Dimethylbenzyl alcohol; Benzyl alcohol, alpha,alpha-dimethyl-; Benzenemethanol, alpha,alpha-dimethyl-; alpha-Cumyl alcohol; 78940_FLUKA; Dimethylphenylcarbinol; AI3-05532; ZINC01591819;α,α-dimethylbenzene methanol;2-phenyl-2-propanol;alpha-dimethylbenzene methanol | C9H12O | 136.19 | CC(C)(C1=CC=CC=C1)O |
| TCMBANKIN059175 | delta-elemene | delta-Elemene; g-elemene; cyclohexene,4-ethenyl-4-methyl-3-[1-methylethenyl]-1-[1-methylethyl]-; δ- elemene | C15H24 | 204.35 | CC(C)C1=CC(C(CC1)(C)C=C)C(=C)C |
| TCMBANKIN059195 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN059262 | diisocapryl phthalate;Diop;diisooctyl phthalate;1,2-benzenedicarboxylic acid,diisooctyl ester | HSDB 588; 1,2-Benzenedicarboxylic acid, diisooctyl ester; bis(6-methylheptyl) benzene-1,2-dicarboxylate; Diisocapryl phthalate; EINECS 248-523-5; Diisooctyl phthalate; 71097-28-4; Phthalic acid, bis(6-methylheptyl)ester; Phthalic acid, diisooctyl ester; AI3-27697-X (USDA); 27554-26-3; Diisooctyl 1,2-benzenedicarboxylate; 1330-91-2; NSC 6381; Di-iso-octyl phthalate; 41375-90-0; benzene-1,2-dicarboxylic acid bis(6-methylheptyl) ester; C14577; DIISOOCTYL PHTHALATE (SEE 27554-26-3); Hexaplas M/O; 25103-50-8; Corflex 880; Flexol Plasticizer DIOP; 1,2-Benzenedicarboxylic acid, 2,2-dimethyl-1,3-propanediyl diisooctyl ester; Isooctyl phthalate | C24H38O4 | 390.6 g/mol | CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC(C)C |
| TCMBANKIN059531 | eucalyptol | C10H18O | 154.25 g/mol | CC1(C2CCC(O1)(CC2)C)C | |
| TCMBANKIN059545 | notoginsenoside a | C54H92O24 | 1125.3 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C(C)(CC=CC(C)(C)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C)O)C)C | |
| TCMBANKIN059644 | sandaracopimarinol | C20H32O | 288.5 g/mol | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)CO)C)C=C | |
| TCMBANKIN059651 | NSC 308879 | C30H52O3 | 460.73 | CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)O)C)C | |
| TCMBANKIN059905 | p-isopropyltoluene;4-Isopropyltoluene;cymene;1-methyl-4-(1-methylethyl)benzene;Cymol;Para cymene;4-Cymol;p-cymene;Dolcymene | C10H14 | 134.22 g/mol | CC1=CC=C(C=C1)C(C)C | |
| TCMBANKIN059910 | alpha-Cuparenol | C15H22O | 218.33 | CC1=CC=C(C=C1)C2(CCC(C2(C)C)O)C | |
| TCMBANKIN059911 | cuparene | C15H22 | 202.33 g/mol | CC1=CC=C(C=C1)C2(CCCC2(C)C)C | |
| TCMBANKIN059962 | cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a． alpha．,8a alpha． )- naphthalene;alpha cadinene;α-muurolene | C15H24 | 204.35 g/mol | CC1=CC2C(CC1)C(=CCC2C(C)C)C | |
| TCMBANKIN059982 | d-limonene | C10H16 | 136.23 g/mol | CC1=CCC(CC1)C(=C)C | |
| TCMBANKIN060009 | copaene; (-)-Alpha-Copaene; α-copaene | C15H24 | 204.35 g/mol | CC1=CCC2C3C1C2(CCC3C(C)C)C | |
| TCMBANKIN060183 | ginsenoside- Re | C48H82O18 | 947.15 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O | |
| TCMBANKIN060401 | acetic acid [(1R,3R,4R,4aS,8aS)-4-hydroxy-3,4a,8,8-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethyl]-1-decalinyl] ester | C22H34O5 | 378.5g/mol | CC1CC(C2C(CCCC2(C1(CCC3=CC(=O)OC3)O)C)(C)C)OC(=O)C | |
| TCMBANKIN060561 | delta-guaiene | C15H24 | 204.35 g/mol | CC1CCC2=C(CCC(CC12)C(=C)C)C | |
| TCMBANKIN060571 | (-)-trifara-9,14-diene | C15H24 | 204.35 g/mol | CC1CCC2C(=C)C1(CCC2(C)C=C)C | |
| TCMBANKIN060652 | cyclo-(ile-val); 3-isopropyl-6-isobutyl-2,5-dioxopiperazine | C11H20N2O2 | 212.29 g/mol | CCC(C)C1C(=O)NC(C(=O)N1)C(C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060774 | (-)2d,4d,6d,8d-tetramethyl undecanoic acid | C15H30O2 | 242.4 g/mol | CCCC(C)CC(C)CC(C)CC(C)C(=O)O | |
| TCMBANKIN060873 | arachidonic acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060897 | enanthic acid | C7H13O2- | 129.18 g/mol | CCCCCCC(=O)[O-] | |
| TCMBANKIN060935 | panaxynol | C17H24O | 244.37 | CCCCCCCC=CCC#CC#CC(C=C)O | |
| TCMBANKIN060944 | nonanoic acid | C9H18O2 | 158.24 g/mol | CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061011 | 1-tridecene; Tridecylene; tridecene | C13H26 | 182.35 | CCCCCCCCCCCC=C | |
| TCMBANKIN061024 | tetradecane | C14H28 | 196.39 g/mol | CCCCCCCCCCCCC=C | |
| TCMBANKIN061043 | MYS | C15H32 | 212.41 | CCCCCCCCCCCCCCC | |
| TCMBANKIN061044 | Pentadecanoate | C15H29O2- | 241.39 g/mol | CCCCCCCCCCCCCCC(=O)[O-] | |
| TCMBANKIN061058 | n-hexadecane | C16H34 | 226.44 g/mol | CCCCCCCCCCCCCCCC | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061085 | n-heptadecane;heptadecane;Heptadekan | C17H36 | 240.5 g/mol | CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061100 | nonadecane | C19H40 | 268.5 g/mol | CCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061101 | Nonadecylic acid | C19H38O2 | 298.5 g/mol | CCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061111 | heneicosane | C21H44 | 296.57 | CCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061112 | heneicosanoicacid | C21H42O2 | 326.6 g/mol | CCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061116 | n-docosane;TWT;docosane | C22H46 | 310.6 g/mol | CCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061141 | n-hentriacontane | C31H64 | 436.8 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061170 | heptadecanol | C17H36O | 256.47 | CCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061174 | Tetradecanol | C14H30O | 214.39 g/mol | CCCCCCCCCCCCCCO | |
| TCMBANKIN061212 | n-butyl pyroglutamate | C9H15NO3 | CCCCOC(=O)C1CCC(=O)N1 | ||
| TCMBANKIN061261 | ethyl pyroglutamate | C7H11NO3 | 157.17 g/mol | CCOC(=O)C1CCC(=O)N1 | |
| TCMBANKIN061269 | 2,2,2-triethoxyethanol | C8H18O4 | 178.23 g/mol | CCOC(CO)(OCC)OCC | |
| TCMBANKIN061477 | vitexicarpin | 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; Casticine; SCHEMBL382354; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one; MolPort-005-938-589; 3',5-Dihydroxy-3,4',6,7-tetramethoxyflavone; Quercetagetin 3,6,7,4'-tetramethyl ether; 3',5-dihydroxy-3,4',6,7-tetramethoxyflavone; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-benzopyran-4-one, 9CI; ZINC6018556; Q-100515; PJQLSMYMOKWUJG-UHFFFAOYSA-N; 4H-1-Benzopyran-4-one,5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; 3,6,7,4'-Tetra-O-methyl-5,3'-dihydroxyflavone; NP-001928; I07-0245; Casticin; V1552; Casticin, United States Pharmacopeia (USP) Reference Standard; casticin; AKOS015896773; CHEMBL452767; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; AC1NSSVS; 3,6,7,4'-tetramethylquercetagetin; FT-0688327; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; Vitexicarpin; 3-,5-Dihydroxy-3,4-,6,7-tetramethoxyflavone; DTXSID80197326; CHEBI:69355; Casticin(Vitexicarpin); AK554014; AN-10374; Agnus castus fruit standardised dry extract, European Pharmacopoeia (EP) Reference Standard; 479-91-4; 753GT729OU; 479V914; Agnus castus fruit dry extract, European Pharmacopoeia (EP) Reference Standard; vitexicarpin ; AC-6085; Casticin, analytical standard; N1318; Agnus castus fruit standardised dry extract; LMPK12113010; Casticin, primary pharmaceutical reference standard; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-chromen-4-one; UNII-753GT729OU;casticin;vitxicarpin | C19H18O8 | 374.34 g/mol | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
| TCMBANKIN061561 | vanillic acid | CJ-02984; CHEBI:16632; Vanillate; CHEBI:30816; H36001_ALDRICH; InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11; BRN 2208364; WKOLLVMJNQIZCI-UHFFFAOYSA-M; 94770_FLUKA; WLN: QVR DQ CO1; MLS000574833; Acide vanillique; vanillicacid; C06672; m-Anisic acid, 4-hydroxy-; VA (VAN); vanil-lic acid; 4-Hydroxy-3-methoxybenzoic acidion; 4-Hydroxy-3-methoxybenzoic acid; Protocatechuic acid, 3-methyl ester; NSC3987; NSC 674322; DB02130; VANILLIC ACID; p-Vanillic acid; NSC 3987; ZB010900; 4-Hydroxy-3-methoxybenzoate; AIDS-018089; p-Hydroxy-m-methoxy-benzonic acid; 3-Methoxy-4-hydroxybenzoic acid; 4-hydroxy-3-methoxy-benzoic acid; NSC674322; 6746-48-1; 121-34-6; AC1L2LVA; Benzoic acid, 4-hydroxy-3-methoxy-; AI3-19542; SMR000156289; AIDS018089; SBB008280; W398802_ALDRICH; EINECS 204-466-8; 4-hydroxy-3-methoxy benzoic acid; 3-methoxy-4-hydroxybenzoic acid | C8H8O4 | 168.15 g/mol | COC1=C(C=CC(=C1)C(=O)O)O |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061786 | elemicine | el-emicine，Elemicine; elemicin ; Elemicin; Benzene, 5-(2-propenyl)-1,2,3-trimethoxy; AX8052814; CJ-04512; C10451; V6154; KS-00000EX2; TC-307841; 4-allyl-1,2,6-trimethoxybenzene; CHEBI:4771; KB-85683; 5-Allyl-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene; NSC16704; K-9190; BRN 1912664; TRA0018883; 5-(Prop-2-en-1-yl)-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene (elemicin); SCHEMBL68542; EINECS 207-649-0; CTK4J0963; 5'-metoxy eugenol; ZB015169; ST24044297; AKOS015896443; CCRIS 6783; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)-; 10005-761a; 1,2,3-Trimethoxy-5-(2-propenyl)-benzene; 1,2,3-trimethoxy-5-(prop-2-en-1-yl)benzene; Benzene,1,2,3-trimethoxy-5-(2-propen-1-yl)-; A827594; 1,2,3-Trimethoxy-5-[2-propenyl]-benzene; I06-1928; 1,2,3-Trimethoxy-5-(2-propenyl)benzene; DTXSID60197586; ZINC899845; 3,4,5-Trimethoxyallylbenzene; MFCD01656688; BPLQKQKXWHCZSS-UHFFFAOYSA-N; AI3-20815; AN-843; CHEMBL458690; 487A116; OR40002; 487-11-6; 5-allyl-1,2,3-trimethoxybenzene; AK116942; ZX-AT003475; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)- (9CI); J-520432; NSC-16704; MolPort-003-824-417; 3,4, 5-Trimethoxyallylbenzene; RP26424; LS-29056; 5-allyl-1,2,3-trimethoxy-benzene; HSZ191AKAN; AC1L1USQ; 4-allyl-1,2,6-trimethoxy benzene; 1,2,3-Trimethoxy-5-(2-propenyl)benzene, 9CI; NSC 16704; AJ-24292; Benzene,2,3-trimethoxy-5-(2-propenyl)-; SY018605; 1,2,3-trimethoxy-5-prop-2-enyl-benzene; 1,2,3-trimethoxy-5-prop-2-enylbenzene; FT-0652063; ST51053296; Benzene, 5-allyl-1,2,3-trimethoxy-; BENZENE, 5-ALLYL-1,2,3-TRIMETHOXY-; DB-081347; 3,5-Trimethoxyallylbenzene; PS-4970; UNII-HSZ191AKAN; 3-(3,4,5-Trimethoxyphenyl)-1-propene; 4-06-00-07478 (Beilstein Handbook Reference) | C12H16O3 | 208.25 g/mol | COC1=CC(=CC(=C1OC)OC)CC=C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab